Skip to content

David Matthew T

Reporting owner on Forms 3, 4 and 5, CIK 1811612.

David Matthew T reported on 1 issuer in 2 filings, the latest a Form 4 filed 2026-10-16.

Issuers

IssuerRoles in the latest filingFilingsLast filed
ATNM · Actinium Pharmaceuticals, Inc.CIK 1388320officer (Chief Financial Officer)12026-10-16

Transactions and holdings

Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.

SecurityDateCodeSharesPriceOwned afterFiling
ATNM · Actinium Pharmaceuticals, I…Common Stock2026-10-14A granted+250,000$0250,000Form 4
ATNM · Actinium Pharmaceuticals, I…Stock Option (right to purchase), derivative2026-10-14A granted+250,000$0250,000Form 4

Filings

The person's Forms 3, 4 and 5, and any 13D or 13G naming it.

FilingSubjectFiledAcceptedIngested
Form 4 0001213900-26-110340 Actinium Pharmaceuticals, Inc.2026-10-16
Form 3 0001213900-26-110337 Actinium Pharmaceuticals, Inc.2026-10-16